Floatz logo

(1,1'-BIPHENYL)-3-CARBOXYLIC ACID, 2',4'-DIFLUORO-4-HYDROXY-

Familial Amyloid Polyneuropathy

Boston UniversitySmall moleculePhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Familial Amyloid Polyneuropathy cohort.

Asset / SponsorPhaseRating
fx-1006a
Qilu Pharmaceutical Co., Ltd.
Phase 4A
fx-1006a
Pfizer
Phase 4BBB
Tegsedi
Akcea Therapeutics
Phase 4BB
Revusiran
Alnylam Pharmaceuticals
Phase 3BB
fx-1006a
Qilu Pharmaceutical Co., Ltd.
Phase 4BB

View all 18 →

Same molecule, other indications

(1,1'-BIPHENYL)-3-CARBOXYLIC ACID, 2',4'-DIFLUORO-4-HYDROXY- is also rated in:

hereditary amyloidosisDormant
B
Indicative ·
61 / 100
View asset →
amyloidosisDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →